CIK 0001799011 · <br>Emerging growth company
Lucid Diagnostics Inc.
Sign in to watch- Ticker
- LUCD
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825488042
- Phone
- 212 949 4319
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +331,210 | $1.66 | $550K | 29,823,094 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +1,479,326 | $1.84 | $2.7M | 31,302,420 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +1,145,086 | $1.84 | $2.1M | 40,253,331 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +197,656 | $2.78 | $550K | 40,450,987 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +221,952 | $2.48 | $550K | 40,672,939 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +331,210 | $1.66 | $550K | 41,004,149 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +1,479,326 | $1.84 | $2.7M | 42,483,475 |
| 2022-09-20 | Lapidus Stanley Director | Sale | −17,000 | $1.71 | $29K | 152,320 |
| 2022-09-20 | Lapidus Stanley Director | Sale | −16,864 | $1.70 | $29K | 135,456 |
| 2022-08-02 | White Debra Director | Grant or award · Employee stock option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-07 | Gordon Michael Adam General Counsel | Grant or award · Employee stock option (right to buy) | +200,000 | 200,000 | ||
| 2022-02-18 | SOKOLOV JACQUE J Director | Grant or award · Employee stock option (right to buy) | +59,000 | 59,000 | ||
| 2022-02-18 | Angagaw Aster Director | Grant or award · Employee stock option (right to buy) | +59,000 | 59,000 | ||
| 2022-02-18 | Lapidus Stanley Director | Grant or award · Employee stock option (right to buy) | +59,000 | 59,000 | ||
| 2022-02-18 | Cox James L Director | Grant or award · Employee stock option (right to buy) | +59,000 | 59,000 | ||
| 2022-02-18 | Sparks Ronald M Director | Grant or award · Employee stock option (right to buy) | +59,000 | 59,000 | ||
| 2022-02-18 | MCGRATH DENNIS M Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +50,000 | 50,000 | ||
| 2022-02-18 | Aklog Lishan Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +75,000 | 75,000 | ||
| 2022-01-07 | MCGRATH DENNIS M Chief Financial Officer | Grant or award | +60,000 | 624,400 | ||
| 2022-01-07 | Aklog Lishan Chief Executive Officer | Grant or award | +60,000 | 624,400 |
Page 4 of 5 · 82 trades